4//SEC Filing
Mazzariello Gina 4
Accession 0000950170-23-043242
CIK 0001658551other
Filed
Aug 16, 8:00 PM ET
Accepted
Aug 17, 4:35 PM ET
Size
4.9 KB
Accession
0000950170-23-043242
Insider Transaction Report
Form 4
Mazzariello Gina
Chief Legal Officer
Transactions
- Sale
Common Stock
2023-08-15$20.88/sh−6,164$128,686→ 49,083 total
Footnotes (2)
- [F1]The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on May 16, 2023.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $20.41 to $21.32. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Documents
Issuer
Amylyx Pharmaceuticals, Inc.
CIK 0001658551
Entity typeother
Related Parties
1- filerCIK 0001913765
Filing Metadata
- Form type
- 4
- Filed
- Aug 16, 8:00 PM ET
- Accepted
- Aug 17, 4:35 PM ET
- Size
- 4.9 KB